B H Long
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 10%
- Cancer Treatment and Pharmacology
Papers in
-
- RNA and protein synthesis mechanisms 4
- Cancer therapeutics and mechanisms 3
- Genomics and Chromatin Dynamics 2
- RNA Research and Splicing 2
-
- Synthetic Organic Chemistry Methods 3
- Co-authors
- C.R. Fairchild (3 shared papers)J. J. Catino (2 shared papers)James Bush (1 shared paper)William T. Bradner (1 shared paper)James K. V. Willson (1 shared paper)Alan E. Levine (1 shared paper)Samit Chakrabarty (1 shared paper)Lynn C. Yeoman (1 shared paper)
- Journals
- Biology of the Cell (2 papers)Cancer and Metastasis Reviews (1 paper)The Journal of Cell Biology (1 paper)The Journal of Antibiotics (1 paper)Medicine (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
B H Long
16 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Toxicology 92
- Oncology 396
- Biotechnology 113
- Pharmacology 181
- Cell Biology 172
Countries citing papers authored by B H Long
This map shows the geographic impact of B H Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B H Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B H Long more than expected).
Fields of papers citing papers by B H Long
This network shows the impact of papers produced by B H Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B H Long. The network helps show where B H Long may publish in the future.
Co-authors
The 25 scholars most cited alongside B H Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 217 | |
| 2 | Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). | 1998 | 175 |
| 3 | 1984 | 175 | |
| 4 | Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. | 1994 | 175 |
| 5 | 1989 | 93 | |
| 6 | Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines. | 1991 | 88 |
| 7 | 1976 | 49 | |
| 8 | Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). | 1992 | 33 |
| 9 | 1997 | 21 | |
| 10 | 1984 | 16 | |
| 11 | 1984 | 16 | |
| 12 | 1982 | 13 | |
| 13 | 2025 | 3 | |
| 14 | 1996 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 0 |
About B H Long
B H Long is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Surgery and Pharmacology, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers), Synthetic Organic Chemistry Methods (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Genomics and Chromatin Dynamics (2 papers), RNA Research and Splicing (2 papers) and Fungal Plant Pathogen Control (2 papers). The work is most often cited by research in Toxicology (92 citations), Oncology (396 citations), Biotechnology (113 citations), Pharmacology (181 citations) and Cell Biology (172 citations). B H Long has collaborated with scholars based in United States, China and Germany. Frequent co-authors include C.R. Fairchild, J. J. Catino, James Bush, William T. Bradner, James K. V. Willson, Alan E. Levine, Samit Chakrabarty, Lynn C. Yeoman, Anna Maria Casazza and Joan M. Carboni. Their work appears in journals such as Biology of the Cell, Cancer and Metastasis Reviews, The Journal of Cell Biology, The Journal of Antibiotics and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.